BMJ  2005;331:869 (15 October), doi:10.1136/bmj.38603.656076.63 (published 6 October 2005)

Paper

Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients

¹ Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, ² Department of Epidemiology and Biostatistics, Erasmus Medical Centre, 3000 DR Rotterdam, Netherlands, ³ SOCAR Research SA, PO Box 2564, CH-1260 Nyon 2, Switzerland, ⁴ School of Public Health, University of Debrecen, H-4028 Debrecen, Hungary, ⁵ Cardiovascular Research Unit, Edinburgh University, Edinburgh EH16 4SB, ⁶ Cardiovascular Sciences, National Heart and Lung Institute, Imperial College London, London SW3 6LY

Objective To derive a risk score for the combination of death from all causes, myocardial infarction, and disabling stroke in patients with stable symptomatic angina who require treatment for angina and have preserved left ventricular function.

Design Multivariate Cox regression analysis of data from a large multicentre trial.

Setting Outpatient cardiology clinics in western Europe, Israel, Canada, Australia, and New Zealand.

Participants 7311 patients with all required data available.

Main outcome measure Death from any cause or myocardial infarction or disabling stroke during a mean follow-up of 4.9 years.

Results 1063 patients either died from any cause or sustained myocardial infarction or disabling stroke. The five year risk of this composite ranged from 4% for patients in the lowest tenth of risk to 35% for patients in the highest tenth. The risk score combines 16 routinely available clinical variables (in order of decreasing contribution): age, left ventricular ejection fraction, smoking, white blood cell count, diabetes, casual blood glucose concentration, creatinine concentration, previous stroke, at least one angina attack a week, coronary angiographic findings (if available), lipid lowering treatment, QT interval, systolic blood pressure 155 mm Hg, number of drugs used for angina, previous myocardial infarction, and sex. Fitting the same model separately to all cause death, myocardial infarction, and stroke gave similar results. The risk score did not seem to predict the nature of the event (death in 39%, myocardial infarction in 46%, and disabling stroke in 15%) or the incidence of angiography or revascularisation, which occurred in 29% of patients.

Conclusion This risk score is an objective aid in deciding on further management of patients with stable angina with the aim of reducing serious outcome events. The score can also be used in planning future trials.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Use a score to predict risks of stable angina
BMJ 2005 331: 0. [Full Text] [PDF]

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

Li Wei, Shah Ebrahim, Christopher Bartlett, Peter D Davey, Frank M Sullivan, and Thomas M MacDonald
BMJ 2005 330: 821. [Abstract] [Full Text] [PDF]

Chronic stable angina: treatment options

Laurence O'Toole and Ever D Grech
BMJ 2003 326: 1185-1188. [Extract] [Full Text] [PDF]

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

Stuart J Pocock, Valerie McCormack, François Gueyffier, Florent Boutitie, Robert H Fagard, and Jean-Pierre Boissel
BMJ 2001 323: 75-81. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Zaman, M. J. MBBS MSc, Junghans, C. PhD, Sekhri, N. MBBS, Chen, R. MD PhD, Feder, G. S. MD, Timmis, A. D. MBBChir MD, Hemingway, H. MBBChir (2008). Presentation of stable angina pectoris among women and South Asian people. CMAJ 179: 659-667 [Abstract] [Full text]  
• Surdacki, A., Marewicz, E., Wieteska, E., Szastak, G., Rakowski, T., Wieczorek-Surdacka, E., Dudek, D., Pryjma, J., Dubiel, J. S. (2008). Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina. Nephrol Dial Transplant 23: 2265-2273 [Abstract] [Full text]  
• Poole-Wilson, P. A., Voko, Z., Kirwan, B.-A., de Brouwer, S., Dunselman, P. H.J.M., Lubsen, J., for the ACTION investigators, (2007). Clinical course of isolated stable angina due to coronary heart disease. Eur Heart J 28: 1928-1935 [Abstract] [Full text]  
• Timmis, A. D, Feder, G., Hemingway, H. (2007). Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 93: 786-791 [Abstract] [Full text]  
• (2007). Stable angina who needs revascularisation?. DTB 45: 12-16 [Abstract] [Full text]  
• Niewoehner, D. E., Lokhnygina, Y., Rice, K., Kuschner, W. G., Sharafkhaneh, A., Sarosi, G. A., Krumpe, P., Pieper, K., Kesten, S. (2007). Risk Indexes for Exacerbations and Hospitalizations Due to COPD. Chest 131: 20-28 [Abstract] [Full text]  
• Krumholz, H. M., Masoudi, F. A. (2006). The Year in Epidemiology, Health Services Research, and Outcomes Research. J Am Coll Cardiol 48: 1886-1895 [Full text]  
• Deckers, J. W., Goedhart, D. M., Boersma, E., Briggs, A., Bertrand, M., Ferrari, R., Remme, W. J., Fox, K., Simoons, M. L., on behalf of the EUROPA Investigators, (2006). Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J 27: 796-801 [Abstract] [Full text]  
• Poole-Wilson, P. A., Jacques, A., Lyon, A. (2006). Treatment of angina: a commentary on new therapeutic approaches. Eur Heart J Suppl 8: A20-A25 [Abstract] [Full text]  
• (2005). Risk Scoring for Patients with Stable Angina. Journal Watch Cardiology 2005: 6-6 [Full text]  
• Terkelsen, C. J., Vach, W. (2005). Can risk score models help in reducing serious outcome events in patients with stable angina?. BMJ 331: 872-872 [Full text]  

Rapid Responses:

Read all Rapid Responses

Epidemiologists and researchers continue to overlook the obvious

Stephen J Bunker, et al.
bmj.com, 21 Oct 2005 [Full text]

A comparison of Clayton and Pocock scores

Ioan A. Gutiu, et al.
bmj.com, 21 Oct 2005 [Full text]

Re: Authors reply: Epidemiologists and researchers continue to overlook the obvious & A comparison of Clayton & Pocock scores

Tim C Clayton, et al.
bmj.com, 3 Nov 2005 [Full text]